Rina K Patel
AstraZeneca (United Kingdom)(GB)AstraZeneca (Spain)(ES)
Publications by Year
Research Areas
Cancer Research and Treatments, Occupational and environmental lung diseases, Botulinum Toxin and Related Neurological Disorders, Nanoparticle-Based Drug Delivery, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.(2007)
- Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.(2007)
- Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines.(2011)
- → What do patients need to know? A study to assess patients' satisfaction with information about medicines(2016)27 cited
- → Management of sickle cell disease in patients undergoing cardiac surgery(2017)24 cited
- → Effect of Concomitant Administration of Trospium Chloride Extended Release on the Steady-State Pharmacokinetics of Metformin in Healthy Adults(2013)17 cited
- → A phase 2, multicenter study of FOLFIRINOX followed by ipilimumab in combination with allogeneic GM-CSF transfected pancreatic tumor vaccine in the treatment of metastatic pancreatic cancer.(2014)6 cited
- → Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program of 1076 Patients(2025)2 cited
- → MORAb-003 inhibits folate-driven growth mediated by the human folate receptor alpha(2006)1 cited
- → Issues and Proposed Solution of E-commerce with Cloud Computing(2019)